BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25209576)

  • 21. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.
    Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu OL; Kluge A; Knudsen GM; Koulibaly PM; Nobili F; Pagani M; Sabri O; Vander Borght T; Van Laere K; Tatsch K
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):213-27. PubMed ID: 23160999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of Reconstruction Strategies for the Quantification and Diagnostic Accuracy of (123)I-FP-CIT SPECT].
    Kameiyama H; Matsutomo N; Nagaki A; Yamao F
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jul; 72(7):595-601. PubMed ID: 27440703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies.
    Söderlund TA; Dickson JC; Prvulovich E; Ben-Haim S; Kemp P; Booij J; Nobili F; Thomsen G; Sabri O; Koulibaly PM; Akdemir OU; Pagani M; van Laere K; Asenbaum-Nan S; George J; Sera T; Tatsch K; Bomanji J
    J Nucl Med; 2013 May; 54(5):714-22. PubMed ID: 23492885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT.
    Yokoyama K; Imabayashi E; Sumida K; Sone D; Kimura Y; Sato N; Mukai Y; Murata M; Matsuda H
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):366-372. PubMed ID: 27544223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L; Ilić TV; Dopudja M; Ajdinović B
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of brain atrophy using semiquantitative analysis in [
    Nosaka H; Onoguchi M; Tsushima H; Suda M; Kurata S; Onoma A; Murakawa R
    Sci Rep; 2022 Jan; 12(1):168. PubMed ID: 34997080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the accuracy and reproducibility of computer-assisted analysis of (123) I-FP-CIT SPECT using BasGan (V2).
    Skanjeti A; Angusti T; Iudicello M; Dazzara F; Delgado Yabar GM; Trevisiol E; Podio V
    J Neuroimaging; 2014; 24(3):257-65. PubMed ID: 23323544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT.
    Nonokuma M; Kuwabara Y; Hida K; Tani T; Takano K; Yoshimitsu K
    Ann Nucl Med; 2016 Nov; 30(9):637-644. PubMed ID: 27438050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head comparison of
    Lee I; Kim JS; Park JY; Byun BH; Park SY; Choi JH; Moon H; Kim JY; Lee KC; Chi DY; Kim KM; Lim I; Kang JH; Ahn SH; Kim BI; Ha JH; Lim SM
    Synapse; 2018 Jul; 72(7):e22032. PubMed ID: 29486515
    [No Abstract]   [Full Text] [Related]  

  • 32. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism.
    Mäkinen E; Joutsa J; Johansson J; Mäki M; Seppänen M; Kaasinen V
    J Neural Transm (Vienna); 2016 Nov; 123(11):1309-1318. PubMed ID: 27324804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
    Chun K; Kong E; Cho I
    Medicine (Baltimore); 2021 Aug; 100(34):e27019. PubMed ID: 34449475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative evaluation of the tracer distribution in dopamine transporter SPECT for objective interpretation.
    Iwabuchi Y; Nakahara T; Kameyama M; Yamada Y; Hashimoto M; Ogata Y; Matsusaka Y; Katagiri M; Itoh K; Osada T; Ito D; Tabuchi H; Jinzaki M
    Ann Nucl Med; 2018 Jun; 32(5):363-371. PubMed ID: 29654576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography.
    Yaqub M; Boellaard R; van Berckel BN; Ponsen MM; Lubberink M; Windhorst AD; Berendse HW; Lammertsma AA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1397-406. PubMed ID: 17191076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
    Stokkel MP; Dibbets-Schneider P; Koestering E; Dragoiescu C; Blokland KA
    J Nucl Med Technol; 2007 Mar; 35(1):21-6. PubMed ID: 17337653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic imaging separates normal pressure hydrocephalus from its mimics.
    Allali G; Garibotto V; Mainta IC; Nicastro N; Assal F
    J Neurol; 2018 Oct; 265(10):2434-2441. PubMed ID: 30155736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
    Hauser RA; Grosset DG
    J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.